Developer docs
API playgroundTry for free, no card

Search company profiles

Logipren

Full company profile

uuid00214n1

Namestring
Logipren
Legal namestring
SAS LogipremF
Websiteurl
logipren.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Logipren, legally SAS LogipremF, is a French medical device software company headquartered in Saint-Pierre, La Réunion, with a commercial office in Paris. The company develops a CE-marked Class IIB computerized prescription order entry and clinical decision support system purpose-built by neonatologists for neonatal and pediatric intensive care units. The platform is anchored by a proprietary Reference Thesaurus covering 700 medications validated by the French Society of Neonatology, which suggests drug protocols based on gestational age, postnatal age, corrected age, weight, and clinical indications while eliminating manual calculations and integrating parenteral and enteral nutrition prescription. The software is deployed as a pure web thin-client on hospital intranets and integrates with hospital information systems via HL7 ADT, IHE PAM, HL7 Pharmacy, and a proprietary REST API, alongside connectors to pharmacy/nutrition robots such as BAXA EM2400, BP'Prep, and MoLactarium.

Logipren sells primarily through an enterprise field sales motion targeting hospital procurement and clinical leadership, with a 4-step implementation process including parametrization by medical and pharmacy referents. Revenue is generated through subscription-based licensing of the software as a regulated medical device, with associated implementation, training, and ongoing support services, complemented by EU and La Réunion regional co-funding for R&D activities. The company serves 60+ healthcare institutions across metropolitan France and overseas territories, with 150,000+ patients treated and 360+ physicians and pharmacists active in the Logipren Community.

The platform is reinforced by the B-PEN Health Data Warehouse, a pseudonymized prescription data repository from 30+ NICUs governed by a Scientific and Ethics Committee including the SFN, SFPC, CEPOI, and INSERM, which produces annual inter-institution benchmarking reports and supports peer-reviewed clinical research. Core technology integration partnerships include Vidal France for drug database cross-validation, Bow Médical DIANE for ICU continuity, Evolucare Save for critical care, and B.Braun for infusion workflows. The company is co-funded by the European Union, the La Réunion Region, and Bpifrance.

Short descriptiontext

Logipren (SAS LogipremF) provides CE-marked Class IIB prescription decision-support software for hospital neonatal and pediatric intensive care units in France. The platform combines a proprietary 700-drug Reference Thesaurus with B-PEN benchmarking data, deployed across 60+ institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neonatal prescription software, clinical decision support, pediatric intensive care software, medical device software, drug reference thesaurus
Industry2 codes
PRIMARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SIC code1 code
  • Services-Health Services8000
Product category
Clinical Decision Support Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software as Medical Device License (Subscription)
TypeSubscription Recurring
Description

Logipren is sold and deployed as a CE-marked Class IIB medical device software license to hospital neonatal and pediatric intensive care units. Revenue is generated through software licensing with associated implementation, parametrization, training, and ongoing support services. The company also benefits from EU and La Réunion regional co-funding for research and development activities.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Pricing details1 tier
1Enterprise hospital licensing
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing listed. Quote-based enterprise licensing model targeting hospital neonatology and pediatric ICU departments. Pricing varies based on institution size, number of beds, and implementation scope.

GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Logipren is a CE-marked Class IIB medical device software that assists with drug and parenteral nutrition prescriptions in neonatal and pediatric intensive care units. It combines a proprietary Reference Thesaurus of 700 medication protocols validated by the French Society of Neonatology with a 3-click prescription engine that automates dosing calculations and integrates drug and nutrition prescription. The platform is deployed as a pure web thin-client on hospital intranets and connects with hospital information systems via HL7, IHE, and a proprietary REST API.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Drug-related errors occur in 1 out of 6 manual prescriptions in neonatology (Horri J et al. J Clin Pharm Ther 2014; Campino et al. An Pediatr 2006). Logipren's electronic prescribing eliminates manual calculations and transcription, reducing this error rate.
+2 more records
Product overview1 text field

Logipren is a unified medical software platform designed by neonatologists for neonatal and pediatric intensive care prescription management. The core offering consists of the Logipren Software (prescription order entry and clinical decision support system with CE Class IIB marking), supported by a proprietary Reference Thesaurus database of 700 medications, the B-PEN Health Data Warehouse for benchmarking and clinical research, and the Logipren Community for professional exchange. The platform provides end-to-end protection from prescription through administration, including drug preparation, enteral and parenteral nutrition management, with integration to hospital systems via HL7 standards and a proprietary REST API.

Product and service4 records
1Logipren Software
CategoryClinical Decision Support Software
Description

CE-marked Class IIB computerized prescription order entry and clinical decision support system designed by neonatologists for neonatal and pediatric intensive care units. Provides drug prescription, parenteral nutrition, and care plan management with a proprietary Reference Thesaurus of 700 medications and 3-click protocol-based prescription that eliminates manual calculations. Deployed as a pure web thin-client on hospital intranets with HL7/IHE integration.

2B-PEN Health Data Warehouse
CategoryHealth Data and Analytics Platform
Description

Centralized prescription database and research platform that aggregates pseudonymized prescription data from 30+ French NICUs participating in the B-PEN (Benchmarking in Neonatology Prescription) program. Enables annual benchmarking reports comparing prescription practices across neonatal units and supports clinical research on drugs and nutrition in neonatology under oversight of a Scientific and Ethics Committee (SFN, SFPC, CEPOI, INSERM).

3Logipren Community
CategoryProfessional Community Platform
Description

Online professional community platform for physicians and pharmacists to exchange on neonatal prescription issues and Reference Thesaurus configuration in real time. Accessible directly from the Logipren software or via smartphone through the Talkspirit application. Includes 360+ members of healthcare professionals who participate in discussions and knowledge sharing.

4Logipren Reference Thesaurus
CategoryDrug Reference Database
Description

Proprietary regularly updated drug database containing prescription protocols for 700 medications most used in neonatology and pediatric intensive care. Rules validated by the Société Française de Néonatologie and combining AMM recommendations, national guidelines (SFN, ANSM, HAS), American Pharmacist Association references, and peer-reviewed international literature. Powers the prescription decision support across all equipped institutions.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Vidal provides the certified drug database (Vidal Médicaments) to which Logipren cross-validates prescriptions, ensuring drug safety and compliance with French HAS certification requirements. Vidal integrates prescription decision-support data into over 200 software products in France and internationally.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The University Hospital of La Réunion is the origin institution of the B-PEN (Benchmarking in Neonatology Prescription) research project that led to Logipren's creation. The hospital hosts the Health Data Warehouse and provides ongoing clinical research collaboration through the Scientific and Ethics Committee (with SFN, SFPC, CEPOI, INSERM).

3CHU de La Réunion / B-PEN Study Group
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The B-PEN (Benchmarking in Neonatology Prescription) program involves 30+ French NICUs contributing pseudonymized prescription data to the Health Data Warehouse. Managed by a Scientific and Ethics Committee including SFN, SFPC, CEPOI, and INSERM representatives. Annual benchmarking reports generated and reviewed at joint hospital meetings.

logipren.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Elsevier Clinical Solutions
TypeBroad incumbent
Description

Elsevier's ClinicalPath, Order Sets, and clinical decision support solutions serve hospitals globally with evidence-based content. As a broad incumbent in evidence-based CDS, Elsevier represents both a content partner opportunity and a competitive threat in clinical decision support for prescribing.

TypeOthers
Description

Vidal is the French certified drug database provider whose data Logipren uses for prescription cross-validation. Vidal is also an enabling technology partner that distributes prescription decision-support data into 200+ software products — making it both a critical dependency and a potential competitor should it vertically integrate into prescription SaaS.

TypeBroad incumbent
Description

Epic's enterprise EHR includes CPOE and clinical decision support with growing pediatric/neonatal content. While not focused exclusively on neonatology, large Epic installations in European academic hospitals represent a potential long-term competitive threat to point solutions like Logipren.

4Oracle Health (formerly Cerner)
TypeBroad incumbent
Description

Oracle Health's EHR and Millennium platform include CPOE and CDS capabilities used in academic hospitals. As a global broad incumbent, it could expand neonatal-specific functionality and compete with Logipren in larger French/European academic medical centers.

TypeBroad incumbent
Description

CompuGroup Medical is a major European health IT vendor with hospital information systems and CPOE offerings. As a broad incumbent, it competes for the same French and European hospital IT budgets and could expand specialty pediatric offerings to challenge Logipren's niche.

TypeDirect peer
Description

Bow Médical's DIANE suite (including DIANE RÉA for ICU prescription) is directly interoperable with Logipren and serves a comparable French hospital critical-care IT market. Both target anesthesia/ICU departments with CPOE functionality, making Bow the closest direct competitor for prescription-management mindshare in French hospitals.

7Maincare Solutions
TypeBroad incumbent
Description

Maincare is a major French hospital IT vendor with EHR and clinical information system offerings. As a broad incumbent, it represents an enterprise-wide alternative that could subsume Logipren's specialty NICU use case within a larger hospital IT contract.

TypeDirect peer
Description

Evolucare's Soins Critiques (Save) suite covers surgical, anesthesia, and ICU operations in French hospitals. It competes for the same critical-care IT budget pool as Logipren, with potential overlap on integrated patient care management across ICU and neonatal environments.

TypeBroad incumbent
Description

Dedalus is a leading European hospital information systems vendor with broad CPOE/EHR offerings across multiple specialties. As a broad incumbent, it competes with Logipren at the hospital-wide IT level and could threaten Logipren by adding deeper neonatal modules to its existing footprint.

TypeOthers
Description

B.Braun is a multi-specialist medical device company whose Spaceplus infusion devices and parenteral nutrition systems integrate with hospital IT. While not a direct software competitor, B.Braun is an adjacent technology/infrastructure partner whose compounding devices connect to neonatal workflows where Logipren operates.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Logipren

Clinical Decision Support Softwarelogipren.com

Logipren (SAS LogipremF) provides CE-marked Class IIB prescription decision-support software for hospital neonatal and pediatric intensive care units in France. The platform combines a proprietary 700-drug Reference Thesaurus with B-PEN benchmarking data, deployed across 60+ institutions.

What Logipren does

Logipren, legally SAS LogipremF, is a French medical device software company headquartered in Saint-Pierre, La Réunion, with a commercial office in Paris. The company develops a CE-marked Class IIB computerized prescription order entry and clinical decision support system purpose-built by neonatologists for neonatal and pediatric intensive care units. The platform is anchored by a proprietary Reference Thesaurus covering 700 medications validated by the French Society of Neonatology, which suggests drug protocols based on gestational age, postnatal age, corrected age, weight, and clinical indications while eliminating manual calculations and integrating parenteral and enteral nutrition prescription. The software is deployed as a pure web thin-client on hospital intranets and integrates with hospital information systems via HL7 ADT, IHE PAM, HL7 Pharmacy, and a proprietary REST API, alongside connectors to pharmacy/nutrition robots such as BAXA EM2400, BP'Prep, and MoLactarium.

Logipren sells primarily through an enterprise field sales motion targeting hospital procurement and clinical leadership, with a 4-step implementation process including parametrization by medical and pharmacy referents. Revenue is generated through subscription-based licensing of the software as a regulated medical device, with associated implementation, training, and ongoing support services, complemented by EU and La Réunion regional co-funding for R&D activities. The company serves 60+ healthcare institutions across metropolitan France and overseas territories, with 150,000+ patients treated and 360+ physicians and pharmacists active in the Logipren Community.

The platform is reinforced by the B-PEN Health Data Warehouse, a pseudonymized prescription data repository from 30+ NICUs governed by a Scientific and Ethics Committee including the SFN, SFPC, CEPOI, and INSERM, which produces annual inter-institution benchmarking reports and supports peer-reviewed clinical research. Core technology integration partnerships include Vidal France for drug database cross-validation, Bow Médical DIANE for ICU continuity, Evolucare Save for critical care, and B.Braun for infusion workflows. The company is co-funded by the European Union, the La Réunion Region, and Bpifrance.

Logipren firmographics

Firmographics
Name
Logipren
Legal name
SAS LogipremF
Website
https://logipren.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Logipren (SAS LogipremF) provides CE-marked Class IIB prescription decision-support software for hospital neonatal and pediatric intensive care units in France. The platform combines a proprietary 700-drug Reference Thesaurus with B-PEN benchmarking data, deployed across 60+ institutions.
Ownership category
akta.pro rank

Logipren industry classification

Industry
Product category
Clinical Decision Support Software
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Neonatal prescription software
  • Clinical decision support
  • Pediatric intensive care software
  • Medical device software
  • Drug reference thesaurus

Where Logipren is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Logipren business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Software as Medical Device License (Subscription): Logipren is sold and deployed as a CE-marked Class IIB medical device software license to hospital neonatal and pediatric intensive care units. Revenue is generated through software licensing with associated implementation, parametrization, training, and ongoing support services. The company also benefits from EU and La Réunion regional co-funding for research and development activities.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise hospital licensing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Logipren product offering

Product offering

Core offering

Logipren is a CE-marked Class IIB medical device software that assists with drug and parenteral nutrition prescriptions in neonatal and pediatric intensive care units. It combines a proprietary Reference Thesaurus of 700 medication protocols validated by the French Society of Neonatology with a 3-click prescription engine that automates dosing calculations and integrates drug and nutrition prescription. The platform is deployed as a pure web thin-client on hospital intranets and connects with hospital information systems via HL7, IHE, and a proprietary REST API.

Product overview

Logipren is a unified medical software platform designed by neonatologists for neonatal and pediatric intensive care prescription management. The core offering consists of the Logipren Software (prescription order entry and clinical decision support system with CE Class IIB marking), supported by a proprietary Reference Thesaurus database of 700 medications, the B-PEN Health Data Warehouse for benchmarking and clinical research, and the Logipren Community for professional exchange. The platform provides end-to-end protection from prescription through administration, including drug preparation, enteral and parenteral nutrition management, with integration to hospital systems via HL7 standards and a proprietary REST API.

Differentiator

Problem solved

Functional benefit

Products and services

  • Logipren Software CE-marked Class IIB computerized prescription order entry and clinical decision support system designed by neonatologists for neonatal and pediatric intensive care units. Provides drug prescription, parenteral nutrition, and care plan management with a proprietary Reference Thesaurus of 700 medications and 3-click protocol-based prescription that eliminates manual calculations. Deployed as a pure web thin-client on hospital intranets with HL7/IHE integration.
  • B-PEN Health Data Warehouse Centralized prescription database and research platform that aggregates pseudonymized prescription data from 30+ French NICUs participating in the B-PEN (Benchmarking in Neonatology Prescription) program. Enables annual benchmarking reports comparing prescription practices across neonatal units and supports clinical research on drugs and nutrition in neonatology under oversight of a Scientific and Ethics Committee (SFN, SFPC, CEPOI, INSERM).
  • Logipren Community Online professional community platform for physicians and pharmacists to exchange on neonatal prescription issues and Reference Thesaurus configuration in real time. Accessible directly from the Logipren software or via smartphone through the Talkspirit application. Includes 360+ members of healthcare professionals who participate in discussions and knowledge sharing.
  • Logipren Reference Thesaurus Proprietary regularly updated drug database containing prescription protocols for 700 medications most used in neonatology and pediatric intensive care. Rules validated by the Société Française de Néonatologie and combining AMM recommendations, national guidelines (SFN, ANSM, HAS), American Pharmacist Association references, and peer-reviewed international literature. Powers the prescription decision support across all equipped institutions.

Quantifiable outcome

  • Drug-related errors occur in 1 out of 6 manual prescriptions in neonatology (Horri J et al. J Clin Pharm Ther 2014; Campino et al. An Pediatr 2006). Logipren's electronic prescribing eliminates manual calculations and transcription, reducing this error rate.
  • +2 more outcomes

Companies that use Logipren

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Logipren technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

Feature5 records

Logipren partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Vidal (Vidal France)coreTechnology or IntegrationVidal provides the certified drug database (Vidal Médicaments) to which Logipren cross-validates prescriptions, ensuring drug safety and compliance with French HAS certification requirements. Vidal integrates prescription decision-support data into over 200 software products in France and internationally.
  • CHU de La RéunioncoreStrategic or Co-development PartnerThe University Hospital of La Réunion is the origin institution of the B-PEN (Benchmarking in Neonatology Prescription) research project that led to Logipren's creation. The hospital hosts the Health Data Warehouse and provides ongoing clinical research collaboration through the Scientific and Ethics Committee (with SFN, SFPC, CEPOI, INSERM).
  • CHU de La Réunion / B-PEN Study GroupcoreStrategic or Co-development PartnerThe B-PEN (Benchmarking in Neonatology Prescription) program involves 30+ French NICUs contributing pseudonymized prescription data to the Health Data Warehouse. Managed by a Scientific and Ethics Committee including SFN, SFPC, CEPOI, and INSERM representatives. Annual benchmarking reports generated and reviewed at joint hospital meetings.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Logipren competitors and assessment

Company assessment

Broad incumbents

  • Elsevier Clinical Solutions: Elsevier's ClinicalPath, Order Sets, and clinical decision support solutions serve hospitals globally with evidence-based content. As a broad incumbent in evidence-based CDS, Elsevier represents both a content partner opportunity and a competitive threat in clinical decision support for prescribing.
  • Epic Systems: Epic's enterprise EHR includes CPOE and clinical decision support with growing pediatric/neonatal content. While not focused exclusively on neonatology, large Epic installations in European academic hospitals represent a potential long-term competitive threat to point solutions like Logipren.
  • Oracle Health (formerly Cerner): Oracle Health's EHR and Millennium platform include CPOE and CDS capabilities used in academic hospitals. As a global broad incumbent, it could expand neonatal-specific functionality and compete with Logipren in larger French/European academic medical centers.
  • CompuGroup Medical: CompuGroup Medical is a major European health IT vendor with hospital information systems and CPOE offerings. As a broad incumbent, it competes for the same French and European hospital IT budgets and could expand specialty pediatric offerings to challenge Logipren's niche.
  • Maincare Solutions: Maincare is a major French hospital IT vendor with EHR and clinical information system offerings. As a broad incumbent, it represents an enterprise-wide alternative that could subsume Logipren's specialty NICU use case within a larger hospital IT contract.
  • Dedalus: Dedalus is a leading European hospital information systems vendor with broad CPOE/EHR offerings across multiple specialties. As a broad incumbent, it competes with Logipren at the hospital-wide IT level and could threaten Logipren by adding deeper neonatal modules to its existing footprint.

Others

  • Vidal (Wolters Kluwer): Vidal is the French certified drug database provider whose data Logipren uses for prescription cross-validation. Vidal is also an enabling technology partner that distributes prescription decision-support data into 200+ software products — making it both a critical dependency and a potential competitor should it vertically integrate into prescription SaaS.
  • B.Braun: B.Braun is a multi-specialist medical device company whose Spaceplus infusion devices and parenteral nutrition systems integrate with hospital IT. While not a direct software competitor, B.Braun is an adjacent technology/infrastructure partner whose compounding devices connect to neonatal workflows where Logipren operates.

Direct peers

  • Bow Médical: Bow Médical's DIANE suite (including DIANE RÉA for ICU prescription) is directly interoperable with Logipren and serves a comparable French hospital critical-care IT market. Both target anesthesia/ICU departments with CPOE functionality, making Bow the closest direct competitor for prescription-management mindshare in French hospitals.
  • Evolucare Technologies: Evolucare's Soins Critiques (Save) suite covers surgical, anesthesia, and ICU operations in French hospitals. It competes for the same critical-care IT budget pool as Logipren, with potential overlap on integrated patient care management across ICU and neonatal environments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Logipren social profiles

Digital presence

Logipren compliance and trust

Trust signal

Compliance4 records

Logipren financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Logipren leadership team

Management profile

Number of profiles

Profiles6 records

Logipren funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Logipren M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Logipren

What does Logipren do?

Logipren is a CE-marked Class IIB medical device software that assists with drug and parenteral nutrition prescriptions in neonatal and pediatric intensive care units. It combines a proprietary Reference Thesaurus of 700 medication protocols validated by the French Society of Neonatology with a 3-click prescription engine that automates dosing calculations and integrates drug and nutrition prescription. The platform is deployed as a pure web thin-client on hospital intranets and connects with hospital information systems via HL7, IHE, and a proprietary REST API.

Is Logipren a public or private company?

Logipren is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Logipren founded?

Logipren was founded in -1. It employs 11 to 50 people.

Where is Logipren based?

Logipren is headquartered in Paris, France, in the Europe region.

How does Logipren make money?

One revenue line is on record: software as Medical Device License (Subscription).

Who are Logipren's main competitors?

Broad incumbents on record are Elsevier Clinical Solutions, Epic Systems, Oracle Health (formerly Cerner), CompuGroup Medical, Maincare Solutions and Dedalus. Others are Vidal (Wolters Kluwer) and B.Braun. Direct peers are Bow Médical and Evolucare Technologies.

Does Logipren have an API?

Yes. Logipren provides a proprietary REST API for enhanced integration with hospital information systems and specialized software. The API enables interoperability with electronic patient records, pharmacy systems, and nutrition management tools.

What industry is Logipren in?

Logipren's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales